This article is a retraction of:
RETRACTED: Neoadjuvant Therapy for Esophageal Adenocarcinoma in the Community Setting—Practice and Outcomes
Frontiers Editorial OfficeA Retraction of the Original Research Article
Neoadjuvant Therapy for Esophageal Adenocarcinoma in the Community Setting—Practice and Outcomes
by Abdo, J., Bertellotti, C. A., Cornell, D. L., Agrawal, D. K., and Mittal, S. K. (2017). Front. Oncol. 7:151. doi: 10.3389/fonc.2017.00151
The journal retracts the 18 July 2017 article cited above.
During a recent review by the Creighton University Institutional Review Board that approved this study, it was found that the authors utilized and included some datasets that were not IRB-approved. Therefore, the study did not receive full ethics committee approval and is being withdrawn.
The authors concur with the retraction and sincerely regret any inconvenience this may have caused to the reviewers, editors, and readers of Frontiers in Oncology.
Citation: Frontiers Editorial Office (2019) Retraction: Neoadjuvant Therapy for Esophageal Adenocarcinoma in the Community Setting—Practice and Outcomes. Front. Oncol. 9:324. doi: 10.3389/fonc.2019.00324
Received: 10 April 2019; Accepted: 10 April 2019;
Published: 24 April 2019.
Approved by:
Giuseppe Giaccone, Georgetown University, United StatesCopyright © 2019 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, editorial.office@frontiersin.org